Prof. Dr. Ersin Özaslan
Est-ce votre profil ? Revendiquez-le et vérifiez vos informations.
Revendiquer le profilPersonne ↔ Maladie
Sur quelles maladies ce médecin travaille-t-il ?
-
Tumeurs colorectales 8 publicationsSource : OpenAlex / PubMed MeSHVoir les publications
- Adénocarcinome 4 publications
- Tumeurs du poumon 4 publications
- Adénome 3 publications
- Tumeurs de l’hypophyse 3 publications
- Tumeurs 3 publications
- Tumeurs du sein 3 publications
- Tumeurs neuroendocrines 3 publications
- Tumeurs du foie 3 publications
- Tumeurs gastro-intestinales 2 publications
- Carcinome à cellules rénales 2 publications
Personne ↔ Maladie
Sur quels sujets ce médecin travaille-t-il ?
Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : acibadem.com.tr.
- Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
- Kolorektal Kanserler (Kolon ve Rektum Kanseri)
- Meme Kanseri
- Mesane Kanseri
- Prostat Kanseri
- Jinekolojik Tümörler ve Kanserler (Rahim, Serviks, Yumurtalık/Over Kanseri vb.)
- Yumurtalık (Over) Kanseri
- Mide Kanseri
- Akciğer Kanseri
- Kolon (Kalın Bağırsak) Kanseri
CV
Formation et expérience
Expérience
- 2018Acıbadem Sağlık Grubuacibadem.com.tr
- 2016 - 2018Kayseri Eğitim Araştırma Hastanesi / Tıbbi Onkolojiacibadem.com.tr
Formation
- 2016Erciyes Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
- 2012Erciyes Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 2007İstanbul Üniversitesi İstanbul Tıp Fakültesi, Üniversiteacibadem.com.tr
Confiance
D’où viennent ces informations ?
La source est indiquée à côté de chaque information. Si vous constatez une erreur, vous pouvez suggérer une correction.
- SpécialitéOncologie médicaleacibadem.com.trD’après la source
- ÉtablissementAcıbadem Kayseri Hastanesiacibadem.com.trD’après la source
- Sujet de travailTumeurs colorectalesDéduit de 8 publications · Version du modèle —D’après la source
- Publications53 publicationsOpenAlexD’après la source
- Dernière synchronisation4 novembre 2026 20:54https://www.acibadem.com.tr/doktor/ersin-ozaslan/acibadem.com.tr
Travaux scientifiques
Publications sur Tumeurs colorectales
-
Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer
Clinical Lung Cancer, 2023
DOI 10.1016/j.cllc.2023.02.009 PMID 37019814 4 citations (Europe PMC) Source : OpenAlex
-
Is SUVmax of 18F-FDG PET/CT Predictive Factor for Malignancy in Gastrointestinal Tract?
Nigerian Journal of Clinical Practice, 2021
DOI 10.4103/njcp.njcp_637_18 PMID 34397034 4 citations (Europe PMC) Source : OpenAlex
-
A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly
Growth Hormone & IGF Research, 2020
DOI 10.1016/j.ghir.2020.101342 PMID 32916586 6 citations (Europe PMC) Source : OpenAlex
-
Chemotherapy at the End of Life
Journal of Palliative Care, 2020
DOI 10.1177/0825859720946505 PMID 32762320 11 citations (Europe PMC) Source : OpenAlex
-
Comorbidity and polypharmacy in patients with breast cancer
Breast Cancer, 2020
DOI 10.1007/s12282-019-01040-8 PMID 31898155 19 citations (Europe PMC) Source : OpenAlex
-
The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
PubMed, 2020
PMID 32521889 7 citations (Europe PMC) Source : OpenAlex
-
Breast carcinoma detected in breast specimens: A fifteen-year single-center experience
Annals of Medical Research, 2019
DOI 10.5455/annalsmedres.2019.05.287 Source : OpenAlex
-
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.
PubMed, 2019
PMID 31786850 1 citation (Europe PMC) Source : OpenAlex
-
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
Clinical and Applied Thrombosis/Hemostasis, 2018
DOI 10.1177/1076029617753538 PMID 29455568 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Rechallenge chemotherapy as a third line treatment option for metastatic colorectal carcinoma
Ortadoğu Tıp Dergisi, 2017
DOI 10.21601/ortadogutipdergisi.296006 Source : OpenAlex